Hemodynamic OptimizaTion in Sitting POsition Surgery Trial

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 28, 2022

Primary Completion Date

July 30, 2024

Study Completion Date

November 30, 2024

Conditions
Hemodynamic InstabilityBlood Pressure, LowOrthopedic Disorder
Interventions
DEVICE

ClearSight

The primary hypothesis is that continuous non-invasive monitoring using ClearSight reduces the incidence of intraoperative hypotensive events (defined by mean arterial pressure below a value of 65 mmHg for more than 1 minute) and the duration of the events themselves, leading to an improvement in patients' outcomes.

Trial Locations (1)

00168

Policlinico A. Gemelli, Rome

All Listed Sponsors
lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER